HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Advantages of salbutamol-tacholiquine inhalation over orciprenaline-tacholiquine inhalation in bronchial asthma].

AuthorsM Scherrer, H Bachofen
JournalSchweizerische medizinische Wochenschrift (Schweiz Med Wochenschr) Vol. 102 Issue 52 Pg. 1911-4 (Dec 30 1972) ISSN: 0036-7672 [Print] Switzerland
Vernacular TitleVorteile der Salbutamol-Tacholiguin- gegenüber der Orciprenalin-Tacholiguin-Inhalation bie Bronchialasthma.
PMID4573887 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
Chemical References
  • Aerosols
  • Bronchodilator Agents
  • Butylamines
  • Drug Combinations
  • Ethanolamines
  • Phenethylamines
  • Metaproterenol
Topics
  • Adult
  • Aerosols
  • Aged
  • Asthma (drug therapy)
  • Bronchodilator Agents (administration & dosage, adverse effects)
  • Butylamines (administration & dosage, adverse effects)
  • Clinical Trials as Topic
  • Drug Combinations
  • Ethanolamines (administration & dosage, adverse effects)
  • Female
  • Humans
  • Hypertension (chemically induced)
  • Hyperventilation (chemically induced)
  • Hypoxia (chemically induced)
  • Male
  • Metaproterenol (administration & dosage, adverse effects, pharmacology)
  • Middle Aged
  • Oxygen Consumption (drug effects)
  • Phenethylamines (administration & dosage, adverse effects)
  • Respiratory Therapy
  • Tachycardia (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: